Pamela Wapnick
Direttore Finanziario/CFO presso METAGENOMI, INC.
Patrimonio netto: 442 236 $ in data 31/05/2024
Posizioni attive di Pamela Wapnick
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| METAGENOMI, INC. | Direttore Finanziario/CFO | 01/09/2023 | - |
Storia della carriera di Pamela Wapnick
Precedenti posizioni note di Pamela Wapnick
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Diality, Inc.
 Diality, Inc. Medical SpecialtiesHealth Technology Diality, Inc. is engaged in manufacturing medical devices. The company is headquartered in Irvine, CA. | Direttore Finanziario/CFO | 01/06/2022 | 01/09/2023 |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Direttore Finanziario/CFO | 01/11/2019 | 01/06/2022 |
| CALCIMEDICA, INC. | Direttore Finanziario/CFO | 01/12/2017 | 01/10/2019 |
| AMGEN INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2011 | 01/03/2016 |
| Direttore Finanziario/CFO | 01/07/2011 | 01/03/2016 | |
| Treasurer | 01/12/2007 | 01/07/2011 | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Direttore Finanziario/CFO | - | - |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Direttore Finanziario/CFO | 01/09/2023 | - |
Formazione di Pamela Wapnick
| Wellesley College | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 10 |
Posizioni
| Director of Finance/CFO | 7 |
| Chief Tech/Sci/R&D Officer | 1 |
| Treasurer | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| METAGENOMI, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
Diality, Inc.
Diality, Inc. Medical SpecialtiesHealth Technology Diality, Inc. is engaged in manufacturing medical devices. The company is headquartered in Irvine, CA. | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Commercial Services |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Pamela Wapnick
- Esperienza
